This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Blogging Remove Edmunds Remove San Diego Related Topics
Venture Capital Funding Capital Technology Startup Develop Geni Research Study Tool More Related Topics >
article thumbnail

Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More

Xconomy

AUGUST 7, 2020

The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on vaccine development and a slew of biotechs are testing compounds, previously intended for a wide range of indications, as potential COVID-19 treatments. billion merger in the digital health sector.

Research 80
Research Develop Development Edmunds 80
article thumbnail

In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions

Xconomy

MAY 31, 2017

Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the world’s most successful cancer immunotherapies, could now treat any tumor with a particular genetic fingerprint.

Study 90
Study Tool Organization Geni 90
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 5,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024